Atrial Fibrillation Trial, Recruiting (NCT07353775)

Atrial Fibrillation Trial, Recruiting NCT07353775 Sponsor: Beijing Anzhen Hospital Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT07353775 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes, or that is ongoing
People aged 18 years or older
People who are already scheduled to have a specific heart procedure called CTI ablation (a procedure that uses heat or cold energy to correct abnormal heart rhythms)
People who are able and willing to sign a consent form agreeing to take part

Who may not be able to join:

People who have already had a CTI ablation procedure in the past
People with significant heart defects present from birth, or a structural abnormality in the area of the heart involved in this procedure
People who have an active blood clot inside their heart
People who are pregnant or currently breastfeeding
People with severely reduced kidney or liver function
People with an active widespread infection or blood poisoning (sepsis)
People whose life expectancy is estimated to be less than 12 months
People who are unable to sign a consent form agreeing to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-18801427775

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07353775

Sponsor: Beijing Anzhen Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: +86-18801427775

More information: https://clinicaltrials.gov/study/NCT07353775

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People diagnosed with atrial fibrillation (an irregular heartbeat) that comes and goes, or that is ongoing
People aged 18 years or older
People who are already scheduled to have a specific heart procedure called CTI ablation (a procedure that uses heat or cold energy to correct abnormal heart rhythms)
People who are able and willing to sign a consent form agreeing to take part

Who may not be able to join:

People who have already had a CTI ablation procedure in the past
People with significant heart defects present from birth, or a structural abnormality in the area of the heart involved in this procedure
People who have an active blood clot inside their heart
People who are pregnant or currently breastfeeding
People with severely reduced kidney or liver function
People with an active widespread infection or blood poisoning (sepsis)
People whose life expectancy is estimated to be less than 12 months
People who are unable to sign a consent form agreeing to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Beijing Anzhen Hospital

Registry

ClinicalTrials.gov

Start date

15 January 2025

Est. completion

15 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Acute Success of CTI Block

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov